Specialty recruitment: round 1 - acceptance and fill rate
The below table provides the latest recruitment data for training positions starting from August 2021.
The current fill rate is for round 1 and round 1A and provides a comparison to the same stage in 2020 and 2019.
|
|
2021 |
2020 |
2019 |
||||||
|
Training Programme |
Posts |
Accepts |
Fill Rate % |
Posts |
Accepts |
Fill Rate % |
Posts |
Accepts |
Fill Rate % |
|
Internal Medicine Training |
1313 |
1313 |
100.00% |
1376 |
1390 |
101.02% |
1364 |
1357 |
99.49% |
|
Anaesthetics |
450 |
450 |
100.00% |
451 |
451 |
100.00% |
450 |
450 |
100.00% |
|
Emergency Medicine |
320 |
320 |
100.00% |
317 |
315 |
99.37% |
331 |
324 |
97.89% |
|
Cardio-thoracic surgery |
5 |
5 |
100.00% |
10 |
10 |
100.00% |
10 |
10 |
100.00% |
|
Clinical Radiology |
300 |
300 |
100.00% |
252 |
251 |
99.60% |
250 |
249 |
99.60% |
|
Community Sexual and Reproductive Health |
5 |
5 |
100.00% |
6 |
6 |
100.00% |
5 |
5 |
100.00% |
|
Core Psychiatry Training |
428 |
425 |
99.30% |
349 |
347 |
99.43% |
412 |
381 |
92.48% |
|
Core Surgical Training |
495 |
476 |
96.16% |
507 |
506 |
99.80% |
515 |
515 |
100.00% |
|
General Practice |
3733 |
3690 |
98.85% |
3549 |
3441 |
96.96% |
3250 |
2981 |
91.72% |
|
Histopathology |
89 |
89 |
100.00% |
81 |
81 |
100.00% |
76 |
76 |
100.00% |
|
Neurosurgery |
13 |
13 |
100.00% |
22 |
22 |
100.00% |
21 |
21 |
100.00% |
|
Obstetrics and Gynaecology |
226 |
226 |
100.00% |
230 |
224 |
97.39% |
231 |
223 |
96.54% |
|
Ophthalmology |
76 |
76 |
100.00% |
59 |
59 |
100.00% |
79 |
79 |
100.00% |
|
Oral and Maxillo-facial Surgery |
10 |
10 |
100.00% |
9 |
9 |
100.00% |
6 |
6 |
100.00% |
|
Paediatrics |
368 |
368 |
100.00% |
394 |
382 |
96.95% |
419 |
347 |
82.82% |
|
Public Health Medicine |
80 |
80 |
100.00% |
70 |
70 |
100.00% |
77 |
77 |
100.00% |
|
Total |
7911 |
7846 |
99.18% |
7682 |
7564 |
98.46% |
7496 |
7101 |
94.73% |
Data was produced at 30/06/2021 from www.oriel.nhs.uk
Further advertisements are underway for Anaesthesia, General Practice and Core Psychiatry, with an anticipated start date in February 2022.